Rheochrysidin

CAS No. 521-61-9

Rheochrysidin( 6-O-methyl Emodin | NSC 251670 )

Catalog No. M14834 CAS No. 521-61-9

Physcion is an anthraquinone from roots of Rheum officinale Baill.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 41 In Stock
25MG 81 In Stock
50MG 135 In Stock
100MG 230 In Stock
200MG 339 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rheochrysidin
  • Note
    Research use only, not for human use.
  • Brief Description
    Physcion is an anthraquinone from roots of Rheum officinale Baill.
  • Description
    Physcion is an anthraquinone from roots of Rheum officinale Baill.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    6-O-methyl Emodin | NSC 251670
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    521-61-9
  • Formula Weight
    284.27
  • Molecular Formula
    C16H12O5
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 1 mg/mL (3.51 mM); DMSO: 6 mg/mL (21.1 mM)
  • SMILES
    O=C1C2=C(C=C(C)C=C2O)C(C3=CC(OC)=CC(O)=C13)=O
  • Chemical Name
    1,8-dihydroxy-3-methoxy-6-methyl-9,10-anthracenedione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ma X, et al. Pest Manag Sci, 2010, 66(7), 718-724.
molnova catalog
related products
  • Cemiplimab

    Cemiplimab (Anti-Human PD-1) is a human monoclonal antibody that inhibits the PD-1/PD-L1 pathway, serving as a checkpoint inhibitor.

  • DATPT

    DATPT is a small molecule 12WLVSKF17 peptide mimetic molecule.DATPT inhibits SNX9-p47phox interactions and inhibits the production of reactive oxygen species and inflammatory cytokines.

  • Flumethasone pivalat...

    Flumethasone pivalate has antipruritic, anti-inflammatory, and vasoconstrictive properties and can be used in studies about adrenocortical suppression, cutaneous atrophy, plasma transcortin binding, and telangiectasia.